[ad_1] Azenta Inc.‘s stock AZTA, +0.59% rose 7% after the biotech company’s fiscal fourth-quarter results…
Healthcare/Life Sciences
-
-
STOCK MARKET
Verve Therapeutics stock falls 40% as analysts question safety of cholesterol-cutting gene-editing treatment
by userby user[ad_1] Verve Therapeutics Inc. shares VERV, -44.39% fell 40% premarket on Monday after the biotech…
-
STOCK MARKET
Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
by userby user[ad_1] Novo Nordisk’s popular weight-loss drug Wegovy significantly cut the risk of heart attack, stroke or…
-
STOCK MARKET
Ryanair shares rise on airline’s dividend plan, Organigram soars on investment and Tesla declines
by userby user[ad_1] Here are some of the biggest movers of the day: Stock gainers: POSCO Holdings…
-
STOCK MARKET
BioNTech’s stock rallies after it posts surprise Q3 profit and revenue that tops estimates
by userby user[ad_1] BioNTech SE’s stock rose 2.5% early Monday after the company posted a surprise profit…
-
STOCK MARKET
Tonix shares sink 29% on discontinued development on depression treatment
by userby user[ad_1] Shares of Tonix Pharmaceuticals TNXP, +2.97% fell Tuesday after the company said it would…
-
STOCK MARKET
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
by userby user[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for…
-
STOCK MARKET
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
by userby user[ad_1] Amgen Inc.’s stock fell 3.3% Tuesday to put it on track for its biggest…
-
STOCK MARKET
Charlie Munger says there’s not much ‘low-hanging fruit left’ as he discusses Apple, Costco vs. Walmart, and EVs
by userby user[ad_1] Investment legend Charlie Munger will tell you. Our call of the day comes from…
-
STOCK MARKET
Intuitive Machines stock climbs on lunar mission plan as McDonald’s edges higher ahead of results
by userby user[ad_1] Here are the biggest movers of the day: Stock gainers: Coherus BioSciences stock CHRS,…